Cell & Gene Therapy for Cancer
Part of Healthcare - Oncology
 GILD | Gilead Sciences Inc | $185.5b | $147.30 | +0.7% | 2.5M |
 ACLX | Arcellx, Inc. Common Stock | $6.7b | $115.06 | -0.0% | 16.1M |
 IOVA | Iovance Biotherapeutics, Inc. Common Stock | $3.9b | $9.63 | +1.6% | 14.1M |
 NTLA | Intellia Therapeutics, Inc | $1.8b | $11.48 | +0.7% | 2.6M |
 IMTX | Immatics N.V. Ordinary Shares | $1.4b | $8.66 | +0.6% | 451.5K |
 VOR | Vor Biopharma Inc. Common Stock | $1.4b | $21.93 | -1.9% | 1.1M |
 SANA | Sana Biotechnology, Inc. Common Stock | $1.2b | $3.00 | -4.9% | 2.1M |
 IMMX | Immix Biopharma, Inc. Common Stock | $1.0b | $11.88 | -2.5% | 1.0M |
 ALLO | Allogene Therapeutics, Inc. Common Stock | $0.7b | $1.67 | -2.6% | 4.2M |
 ARTV | Artiva Biotherapeutics, Inc. Common Stock | $0.6b | $8.57 | -3.8% | 342.2K |
 IPSC | Century Therapeutics, Inc. Common Stock | $382.1m | $1.88 | -5.6% | 657.3K |
 LYEL | Lyell Immunopharma, Inc. Common Stock | $366.5m | $10.57 | -3.1% | 103.8K |
 FATE | Fate Therapeutics, Inc. | $293.6m | $2.44 | +2.6% | 759.0K |
 YDES | YD Bio Limited Ordinary Shares | $260.0m | $3.53 | -14.3% | 619.6K |
 TARA | Protara Therapeutics, Inc. Common Stock | $225.7m | $3.69 | -1.5% | 1.5M |
 NKTX | Nkarta, Inc. Common Stock | $199.8m | $2.83 | -1.4% | 467.5K |
 CRBU | Caribou Biosciences, Inc. Common Stock | $171.5m | $1.25 | -1.2% | 540.8K |
 ENGN | enGene Therapeutics Inc. Common Stock | $126.6m | $1.89 | -0.5% | 463.3K |
 ANIX | Anixa Biosciences, Inc. | $106.5m | $2.60 | -3.2% | 284.3K |
 ATRA | Atara Biotherapeutics, Inc | $94.8m | $9.77 | -1.4% | 51.8K |
 ACET | Adicet Bio, Inc. Common Stock | $86.7m | $9.26 | +8.5% | 178.0K |
 COEP | Coeptis Therapeutics Holdings Inc. Common Stock | $66.7m | $16.39 | -0.1% | 105.9K |
 INKT | MiNK Therapeutics, Inc. Common Stock | $57.8m | $11.41 | +1.7% | 3.9K |
 CELU | Celularity Inc. Class A Common Stock | $53.8m | $1.32 | +4.8% | 168.5K |
 TVGN | Tevogen Inc. Common Stock | $46.7m | $7.37 | 0.0% | 2.5K |
 ESLA | Estrella Immunopharma, Inc. Common Stock | $30.0m | $0.64 | +5.5% | 37.8K |
 TCRX | TScan Therapeutics, Inc. Common Stock | $25.1m | $0.33 | +2.5% | 715.8K |
 LNAI | Lunai Bioworks Inc. Common Stock | $10.9m | $2.17 | -0.5% | 25.9K |
 INAB | IN8bio, Inc. Common Stock | $10.8m | $1.05 | 0.0% | 27.5K |
 SNTI | Senti Biosciences Holdings, Inc. Common Stock | $10.6m | $0.32 | +10.0% | 5.5M |
 GDTC | CytoMed Therapeutics Limited Ordinary Shares | $10.4m | $0.84 | 0.0% | 950 |
 ERNA | Ernexa Therapeutics Inc. Common Stock | $5.3m | $3.96 | -3.9% | 18.9K |
 PMCB | PharmaCyte Biotech, Inc. Common Stock | $5.3m | $0.41 | +10.9% | 3.2M |
 MBIO | Mustang Bio, Inc. | $4.2m | $0.51 | +1.3% | 11.4K |
 CLDI | Calidi Biotherapeutics, Inc. | $3.5m | $1.18 | +2.6% | 30.1K |